Adrecizumab Phase 1 Trial (Q66075881)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adrecizumab Phase 1 Trial |
clinical trial |
Statements
A Randomized Double-blind Placebo-controlled Phase 1 Study on the Safety, Tolerability and Pharmacokinetics/-Dynamics of Escalating Single Intravenous Doses of ADRECIZUMAB (HAM8101) in Healthy Male Subjects (English)
0 references
23 May 2016
0 references
22 September 2016
0 references
24
0 references
18 year
0 references
35 year
0 references